Saxenda patent expiry?

There isn’t a single “Saxenda patent expiry” date. Saxenda (liraglutide) is protected by multiple patent families (the molecule itself, salts/formulations, methods of use, etc.) and by regulatory data exclusivity. Expiry depends on the country/region and on which patent or exclusivity you mean.

If you want precise dates, tell me:
- the country/region (e.g., US, EU, UK, Japan, etc.)
- whether you care about patents (composition/use/formulation patents) or regulatory exclusivity (data protection)

I can then pull the current expiry dates from sources like the US FDA Orange Book, USPTO patent records, and the European Patent Office (and explain any extensions or pediatric/regulatory extensions that apply).

Short note: in the US, laxruglutide (Victoza/Saxenda) is a biologic, so data exclusivity (and any indication-specific protections) can affect timing of generic/biosimilar entry even after patent expiry; in many markets a precise entry date won’t be clear until those exclusivities are considered.